FDA priority review

opening door to brick wall
Biotech

Senate hearing takes aim at FDA's rare disease review process

“The members of the panel were like talking to a brick wall,” Jeremy Schmahmann, M.D., testified about his experience at three FDA panels.
Gabrielle Masson Feb 26, 2026 3:50pm
Capitol Building and Congress
Favicon Fierce Pharma

FDA’s rare pediatric voucher program revived by funding bill

Feb 4, 2026 3:12pm
Makary

2 lawmakers push for answers as questions swirl over FDA program

Nov 25, 2025 10:30am
now hiring

FDA unveils hiring spree, new comms program to speed reviews

Nov 21, 2025 11:43am
accelerated

FDA aims for September approval decision for Stealth's drug

Aug 21, 2025 10:15am
Man hands gold dollar sign to another man
Favicon Fierce Pharma

Bavarian Nordic's $160M PRV price reflects new realities

Jun 18, 2025 11:47am